transparent gif
ImmuneSupport.com Home  
Dental amalgam and multiple sclerosis:
A systematic review and meta-analysis
Fibromyalgia & Chronic Fatigue Syndrome Home Page Fibromyalgia & Chronic Fatigue Syndrome Library Fibromyalgia & Chronic Fatigue Syndrome Treatment and Research Email bulletins Fibromyalgia & Chronic Fatigue Syndrome Products Fibromyalgia & Chronic Fatigue Syndrome Community Area Fibromyalgia & Chronic Fatigue Syndrome About Us transparent gif transparent gif
transparent gif
Health Watch Newsletter background The Latest News Articles background The Latest Abstracts background The Latest Drug News background
Search Our Site
 
Home
Fibromyalgia Resources

Chronic Fatigue Syndrome Resources

E-mail Bulletin
Store
Community
About Us

Your Support Funds Research & Advocacy

Dental amalgam and multiple sclerosis: A systematic review and meta-analysis


by KK Aminzadeh and M Etminan
ImmuneSupport.com


05-03-2007

Advertisement

Journal: Journal of Public Health Dentistry. 2007 Winter; 67(1):64-6.

Authors and Affiliations: Aminzadeh KK, Etminan M. Center for Clinical Epidemiology and Evaluation, Vancouver Hospital, Vancouver, Canada.

PMID: 17436982

Objectives: Amalgam restorations have long been controversial due to their mercury content. Allegations that the mercury may be linked to nervous disorders such as Alzheimer's, Chronic Fatigue Syndrome, and multiple sclerosis (MS) have fueled the calls for the removal of amalgam restorations from dentists' armamentarium.

To explore and quantify the association between amalgam restorations and MS we have conducted a systematic review and meta-analysis of the literature.

Methods: A systematic search in Medline (from 1966 to April 2006), EMBASE (2006, Week 16), and the Cochrane library (Issue 2, 2006) for English-language articles meeting specific definitions of MS and amalgam exposure was conducted. Studies were also identified using the references of retrieved articles. Studies were independently reviewed by two authors and disagreements were resolved by consensus. Studies were selected based on an a priori of defined criteria.

Odds ratios (ORs) or relative risks were pooled using the random effects model. Heterogeneity was assessed using Q statistics.

Results: The pooled OR for the risk of MS among amalgam users was consistent, with a slight, nonstatistically significant increase between amalgam use and risk of MS.

Conclusion: Future studies that take into consideration the amalgam restoration size and surface area along with the duration of exposure are needed in order to definitively rule out any link between amalgam and MS.

  Newsletter SignUp Discuss (0 comments) Email Article Print Page
Related Articles:
Real-Time High Resolution 3D Imaging of the Lyme Disease Spirochete Adhering to and Escaping from the Vasculature of a Living Host – Source: PLoS Pathogens, Jun 2008
Rating of 3.3
The Challenge of Multiple Chemical Sensitivity – Source: Journal of Environmental Health, June 2008
Clocking the Lyme spirochete – Source: PLoS ONE, Feb 2008
Rating of 3.5
Do diseases have a prestige hierarchy? A survey among physicians and medical students
Rating of 2.9
Intraepithelial gammadelta+ Lymphocytes: A Comparative Study Between Celiac Disease, Small Intestinal Bacterial Overgrowth, and Irritable Bowel Syndrome
Rating of 3

Every purchase funds research, donations and the community resources provided within our website.

Organic & pure - 100% acacia
RenewLife Clear Fiber

Buffered for easy absorption
Pro-C Complex™ 500mg

Our new proprietary energy NADH
Energy NADH™ 10 mg

Getting your daily supplements has never been easier!
Daily Health ProPack™

A detox your body will soak up!
Infinity Detox Brew BathTea Cream

At ProHealth we believe in "commerce with compassion."

Weekly Special





[ Be the first to comment on this article ]
DISCUSS THIS ARTICLE  (0 existing comments)
Post a Comment
transparent gif
transparent gif transparent gif transparent gif

Home | Library | Email Bulletins | Store | Community | Affiliates


ProHealth's ImmuneSupport.com- The World's Largest Fibromyalgia & Chronic Fatigue Syndrome Website!
Email US or Call US at 1-800-366-6056
Monday-Friday, 7 a.m.-5 p.m. PST
International Callers can reach us at 001.805.564.3064
Copyright © 2008 ProHealth, Inc.
About us, Affiliates, Careers, Contact us, Privacy, 30-day Money Back Guarantee